- Home
- FENC vs CIO Comparison
FENC vs CIO Comparison
Compare FENC & CIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FENC | CIO |
|---|---|---|
| Founded | 1996 | 2013 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 258.5M | 278.5M |
| IPO Year | 2001 | 2014 |
Fundamental Metrics
Financial Performance| Metric | FENC | CIO |
|---|---|---|
| Price | $7.58 | $6.96 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $13.50 | N/A |
| AVG Volume (30 Days) | 154.3K | ★ 501.7K |
| Earning Date | 11-13-2025 | 02-19-2026 |
| Dividend Yield | N/A | ★ 4.32% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $38,790,000.00 | ★ $163,795,000.00 |
| Revenue This Year | N/A | $0.32 |
| Revenue Next Year | $75.22 | $3.20 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.68 | $4.19 |
| 52 Week High | $9.92 | $7.01 |
Technical Indicators
Market Signals| Indicator | FENC | CIO |
|---|---|---|
| Relative Strength Index (RSI) | 45.98 | 62.82 |
| Support Level | $7.50 | $6.94 |
| Resistance Level | $8.00 | $6.97 |
| Average True Range (ATR) | 0.29 | 0.03 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 43.08 | 94.74 |
Price Performance
Historical ComparisonAbout FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About CIO City Office REIT Inc.
City Office REIT Inc is a real estate investment trust. It is focused on acquiring, owning, and operating high-quality office properties located predominantly in Sun Belt markets. The principal objective of the company is to provide attractive risk-adjusted returns to its investors over the long-term through a combination of dividends and capital appreciation. Its properties includes: Pima Center, SanTan, Park Tower, Intellicenter, Intellicenter, Denver Tech, Canyon Park, AmberGlen and many. The company own these office buildings in the metropolitan areas of Dallas, Denver, Orlando, Phoenix, Portland, Raleigh, San Diego, Seattle, and Tampa.